Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies.
作者信息
Squire Jacqueline D, Joshi Avni Y
机构信息
Division of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic, Jacksonville, FL, USA.
Division of Pediatric Allergy & Immunology, Mayo Clinic Children's Center, Rochester, MN, USA.
出版信息
J Clin Immunol. 2021 Oct;41(7):1527-1530. doi: 10.1007/s10875-021-01101-8. Epub 2021 Jul 22.
Abstract
摘要
相似文献
1
Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies.接受补充免疫球蛋白治疗的免疫缺陷患者接种新冠病毒疫苗的安全性
J Clin Immunol. 2021 Oct;41(7):1527-1530. doi: 10.1007/s10875-021-01101-8. Epub 2021 Jul 22.
2
T cell-oriented strategies for controlling the COVID-19 pandemic.以 T 细胞为导向的策略控制 COVID-19 大流行。
Nat Rev Immunol. 2021 Nov;21(11):687-688. doi: 10.1038/s41577-021-00625-9.
3
An Open Letter: COVID-19 and Cancer.一封公开信：新冠疫情与癌症
Cancer. 2021 Apr 15;127(8):1171. doi: 10.1002/cncr.33576.
4
Covid-19 challenges to immune investigations and therapies.新冠病毒对免疫研究和治疗的挑战。
Int Immunopharmacol. 2021 Jun;95:107543. doi: 10.1016/j.intimp.2021.107543. Epub 2021 Feb 27.
5
COVID-19 vaccines: acting on the evidence.COVID-19 疫苗：基于证据采取行动。
Nat Med. 2021 Feb;27(2):183. doi: 10.1038/s41591-021-01261-5.
6
Herd immunization with childhood vaccination may provide protection against COVID-19.群体免疫接种儿童疫苗可能对预防 COVID-19 提供保护。
Acta Microbiol Immunol Hung. 2020 Sep 26;67(3):198-200. doi: 10.1556/030.2020.01207.
7
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.接种BNT162b2 mRNA疫苗后，医护人员和八旬老人针对新冠病毒的年龄和性别依赖性抗体反应。
Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24.
8
Cancer Centers, Organizations Call for COVID-19 Vaccine for Patients With Cancer, Survivors.癌症中心、组织呼吁为癌症患者及幸存者接种新冠疫苗。
Cancer. 2021 Apr 15;127(8):1170-1171. doi: 10.1002/cncr.33575.
9
Vaccinology - Editorial.疫苗学——编者按
Semin Immunol. 2020 Aug;50:101439. doi: 10.1016/j.smim.2020.101439. Epub 2020 Dec 7.
10
COVID-19 Australia: Epidemiology Report 41: Reporting period ending 9 May 2021.澳大利亚2019冠状病毒病：流行病学报告第41号：报告期截至2021年5月9日。
Commun Dis Intell (2018). 2021 May 17;45. doi: 10.33321/cdi.2021.45.26.
引用本文的文献
1
Regulation of innate and adaptive immunity using herbal medicine: benefits for the COVID-19 vaccination.使用草药调节先天性和适应性免疫：对新冠疫苗接种的益处。
Acupunct Herb Med. 2022 Sep;2(3):196-206. doi: 10.1097/HM9.0000000000000046. Epub 2022 Dec 8.
2
COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events.原发性免疫缺陷病患者的 COVID-19 疫苗接种：一项针对患者疫苗犹豫和自我报告不良事件的国际调查。
Front Immunol. 2023 Apr 18;14:1166198. doi: 10.3389/fimmu.2023.1166198. eCollection 2023.
3
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.在主要为抗体缺陷个体中接种三剂新冠病毒mRNA疫苗后引发的免疫反应动力学。
iScience. 2022 Nov 18;25(11):105455. doi: 10.1016/j.isci.2022.105455. Epub 2022 Oct 28.
4
Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunity.免疫不完善的免疫系统：免疫缺陷患者的 2019 年冠状病毒病疫苗接种。
Ann Allergy Asthma Immunol. 2022 Nov;129(5):562-571.e1. doi: 10.1016/j.anai.2022.06.009. Epub 2022 Jun 16.
Zotero 插件